Start a 510(k) Pathway Strategy Firm for Radiology AI

1. 1

   Master the 510(k) pathway and why it dominates

   About 97 percent of radiology AI clears via the 510(k) pathway, which demonstrates substantial equivalence to an existing predicate device and is faster than the de novo or premarket approval routes. Understanding why radiology AI uses this pathway so heavily, and how to use it well, is the foundation. Predicate strategy is where speed to market is won or lost.

2. 2

   Develop predicate and claims strategy

   The specialized skill is choosing the right predicate, structuring the intended-use claim, and assembling the evidence so a submission clears quickly and defensibly. Small strategic choices change timelines by months. This strategic layer, not just form-filling, is what you sell to AI companies.

3. 3

   Advise on the whole product, not just the filing

   Regulatory strategy should shape the product from the start (what it claims, how it is validated, which predicate it targets), so advise early rather than at submission. Founders who treat FDA as a late-stage checkbox pay in delays. Position as a strategic partner who de-risks the roadmap.

4. 4

   Address the evidence-gap tension honestly

   The same streamlined pathway that speeds clearance is why only about 5 percent of radiology AI is prospectively tested, and buyers increasingly demand more evidence than clearance requires. Advise clients on both fast clearance and the validation the market now expects. Honest strategy balances speed with credibility.

5. 5

   Extend the strategy beyond radiology

   The 510(k) predicate approach is transferable to other medical-device categories seeking faster entry, so your expertise can serve adjacent device markets too. Radiology AI is the densest proving ground, but the method travels. Decide whether to specialize in imaging AI or serve device regulatory strategy broadly.

6. 6

   Distinguish from generic 510(k) consulting

   Generic FDA 510(k) device consulting already exists in this library; this card is the radiology-AI-focused, predicate-strategy angle specifically, close to the field's evidence and buyer expectations. Be clear on your niche, because imaging-AI regulatory strategy is deeper and more current than general device filing. It also pairs with the validation and value-assessment services.

Do not take our word for the money. Put your own numbers in and see what this idea has to earn before it works. Free, instant, no account needed.